These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32839593)

  • 21. A half-billion-dollar bid to head off emerging diseases.
    Cohen J
    Science; 2017 Jan; 355(6322):237. PubMed ID: 28104849
    [No Abstract]   [Full Text] [Related]  

  • 22. Russia's fast-track coronavirus vaccine draws outrage over safety.
    Callaway E
    Nature; 2020 Aug; 584(7821):334-335. PubMed ID: 32782400
    [No Abstract]   [Full Text] [Related]  

  • 23. Public-private partnerships and global health equity: prospects and challlenges.
    Asante AD; Zwi AB
    Indian J Med Ethics; 2007; 4(4):176-80. PubMed ID: 18630239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus shuts down trials of drugs for multiple other diseases.
    Ledford H
    Nature; 2020 Apr; 580(7801):15-16. PubMed ID: 32214240
    [No Abstract]   [Full Text] [Related]  

  • 26. A Global Collaborative to Advance Genomic Medicine.
    Ginsburg GS
    Am J Hum Genet; 2019 Mar; 104(3):407-409. PubMed ID: 30849327
    [No Abstract]   [Full Text] [Related]  

  • 27. Eliminating neglected diseases in poor countries: a conversation with Andrew Witty. Interview by Susan Dentzer.
    Witty A
    Health Aff (Millwood); 2009; 28(3):w411-6. PubMed ID: 19299425
    [No Abstract]   [Full Text] [Related]  

  • 28. 'Nice guys, your reps, right?'.
    Kochen MM
    Eur J Gen Pract; 2010 Sep; 16(3):129-30. PubMed ID: 20672872
    [No Abstract]   [Full Text] [Related]  

  • 29. The Health Impact Fund: a potential solution to inequity in global drug access.
    Banerjee A; Pogge T
    Indian J Med Ethics; 2010; 7(4):240-3. PubMed ID: 22106579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.
    Burci GL; Gostin LO
    JAMA; 2017 Feb; 317(5):473-474. PubMed ID: 28170485
    [No Abstract]   [Full Text] [Related]  

  • 31. Too little, too late.
    Sci Am; 2009 Oct; 301(4):30. PubMed ID: 19780447
    [No Abstract]   [Full Text] [Related]  

  • 32. Shot in the arm. H1N1 vaccine is headed to state health departments to ward off pandemic's spread, but experts worry about delay.
    Zigmond J
    Mod Healthc; 2009 Oct; 39(43):6-7, 16, 1. PubMed ID: 19972647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global Cancer Clinical Trials-Cooperation Between Investigators in High-Income Countries and Low- and Middle-Income Countries.
    Panda PK; Jalali R
    JAMA Oncol; 2018 Jun; 4(6):765-766. PubMed ID: 29566116
    [No Abstract]   [Full Text] [Related]  

  • 34. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
    Røttingen JA; Regmi S; Eide M; Young AJ; Viergever RF; Ardal C; Guzman J; Edwards D; Matlin SA; Terry RF
    Lancet; 2013 Oct; 382(9900):1286-307. PubMed ID: 23697824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rapidly increasing cost of medicines threatens the core of healthcare.
    Werkö L
    Scand Cardiovasc J; 2004 Jun; 38(3):130-1. PubMed ID: 15223707
    [No Abstract]   [Full Text] [Related]  

  • 36. Cautionary Notes on a Global Tiered Pricing Framework for Medicines.
    Williams OD; Ooms G; Hill PS
    Am J Public Health; 2015 Jul; 105(7):1290-3. PubMed ID: 25973806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.
    Partridge J; Kieny MP;
    Vaccine; 2010 Jul; 28(30):4709-12. PubMed ID: 20488262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social responsibility and global pharmaceutical companies.
    Daniels N
    Dev World Bioeth; 2001 May; 1(1):38-41. PubMed ID: 12870507
    [No Abstract]   [Full Text] [Related]  

  • 39. Access to medicines in developing countries: ethical demands and moral economy.
    Cassier M; Correa M
    Dev World Bioeth; 2014 Aug; 14(2):ii-viii. PubMed ID: 25039326
    [No Abstract]   [Full Text] [Related]  

  • 40. [Flu vaccines].
    Pfleiderer M
    Pharm Unserer Zeit; 2011 Mar; 40(2):126-34. PubMed ID: 21630538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.